CLOV vs HOMB · rev $1.37B vs P/E 11, $5.53B cap
Clover Health Investments Corp (CLOV) versus Home BancShares Inc (HOMB) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Home BancShares Inc (HOMB) is a banks - regional company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
HOMB does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. HOMB currently screens at market cap $5.53B and trailing P/E 11.3.
Not investment advice. Open the CLOV and HOMB stock pages for the full models.
Not investment advice.